State of New Jersey Common Pension Fund D’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,427
Closed -$2.43M 1709
2022
Q1
$2.43M Buy
4,427
+515
+13% +$311K 0.01% 1426
2021
Q4
$2.58M Buy
3,912
+528
+16% +$404K 0.01% 1526
2021
Q3
$2.84M Buy
3,384
+741
+28% +$752K 0.01% 1175
2021
Q2
$3.35M Buy
2,643
+1,058
+67% +$1.19M 0.01% 966
2021
Q1
$1.74M Sell
1,585
-1,083
-41% -$1.43M 0.01% 1612
2020
Q4
$3.81M Sell
2,668
-143
-5% -$153K 0.01% 867
2020
Q3
$1.98M Sell
2,811
-626
-18% -$455K 0.01% 1429
2020
Q2
$2.4M Buy
+3,437
New +$1.98M 0.01% 1075

Other funds holding CDLX

State of New Jersey Common Pension Fund D's CDLX Position: Q2 2022 in Review

State of New Jersey Common Pension Fund D sold out of Cardlytics (CDLX) in Q2 2022, closing a stake of 4,427 shares — an estimated $2.43M sold.

State of New Jersey Common Pension Fund D first reported a position in CDLX in Q2 2020 and held it in 8 quarters. The position peaked at $3.81M in Q4 2020. 138 funds tracked by Wall St. Rank hold CDLX as of Q2 2022.

  • State of New Jersey Common Pension Fund D reported no remaining Cardlytics position as of Q2 2022 after selling out during the quarter.
  • State of New Jersey Common Pension Fund D sold 4,427 Cardlytics shares in Q2 2022, an estimated $2.43M.
  • State of New Jersey Common Pension Fund D first reported a position in Cardlytics in Q2 2020 and held it in 8 quarters.
  • State of New Jersey Common Pension Fund D's Cardlytics position peaked at $3.81M in Q4 2020.
  • 138 funds tracked by Wall St. Rank held Cardlytics as of Q2 2022.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2022, filed 4 Aug 2022.